New hope for XLRP patients; gene therapy may slow or cure vision loss.
Read More »
Novo Nordisk's Victoza approved for new indication by FDA
Research shows benefits of adhering to diabetes medication
Genentech's Actemra receives approval from FDA to treat CRS patients
Avella Specialty Pharmacy again recognized by Inc. Magazine